CAR T-cell therapy, which uses genetically enhanced versions of a patient's own cancer-fighting T-cells, is revolutionizing ...

However, one significant challenge is this therapy has a high rate of relapse, even in patients who first achieve complete remission. Now, a novel approach is helping to keep patients’ cancer ...

The therapy has a high rate of relapse, even in patients who first achieve complete remission. Now, a novel approach is helping to keep patients’ cancer-free for longer. First there was chemo ...